NEW YORK (Reuters Health) – Exposure to bisphenol A (BPA), a chemical used in the resins that line food and beverage containers and in the production of polycarbonate…
NEW YORK (Reuters Health) – Treatment with the phosphodiesterase inhibitor pentoxifylline can significantly reduce proteinuria in patients with diabetic and other forms of chronic kidney disease, according to…
NEW YORK (Reuters Health) – Findings from a new study suggest that contrary to what some researchers have hypothesized, migraine is not associated with atherosclerosis, but it may…
NEW YORK (Reuters Health) – In elderly patients with rheumatoid arthritis, treatment with tumor necrosis factor (TNF)-alpha antagonists may increase their risk of new-onset heart failure, and exacerbate…
NEW YORK (Reuters Health) – Gastric acid suppression by proton pump inhibitors (PPIs) is associated with an increased risk of Clostridium difficile-related diarrhea in hospitalized patients, results of…
NEW YORK (Reuters Health) – For patients with radiation or chemical cystitis refractory to standard therapy, submucosal injection of botulinum toxin A (BoNT-A) into the bladder wall appears…
Hylton Mayer, MD at the Yale Eye Center discusses the pros and cons of multifocal intraocular lenses. References and Resources Kumar BV, Phillips RP, Prasad S. Multifocal intraocular…
NEW YORK (Reuters Health) – Researchers from Spain have found a strong and independent link between cannabis use and early age at onset of psychosis. The association, they…
NEW YORK (Reuters Health) – Vascular-targeted photodynamic therapy (VTP) using the light-activated drug Tookad offers promise as an effective, minimally invasive salvage therapy for men with recurrent prostate…
NEW YORK (Reuters Health) – The results of a new study suggest that patients receiving long-term warfarin therapy do not need to stop the drug prior to coronary…
